Skip to main content

Month: May 2020

Rovio Entertainment Oyj: Omien osakkeiden hankinta 11.05.2020

Rovio Entertainment Oyj – Omien osakkeiden hankinta 11.05.2020Rovio Entertainment Oyj                             PÖRSSITIEDOTE                  11.05.2020 klo 18.45Helsingin PörssiPäivämäärä                                                11.05.2020Pörssikauppa                                             OstoOsakelaji                                                    ROVIOOsakemäärä                                               56565             osakettaKeskihinta/osake                                        5,515271         euroaKokonaiskustannus                                    311971,30       euroaYhtiön hallussa on 11.05.2020 tehtyjen kauppojen jälkeen 5 634 683 osaketta.Rovio Entertainment Oyj:n puolestaOP Yrityspankki OyjMarko Niemi                                Antti KerätärLisätietoja:Rene Lindell, talousjohtaja+358 207 888 300...

Continue reading

Elis announced the closing of the acquisition of Central Laundry in the UK

Elis announced the closing of the acquisition ofCentral Laundry in the UKSaint-Cloud, 11 May 2020 – Elis, an international multi-service provider, offering textile, hygiene and facility services solutions across Europe and Latin America, is continuing its expansion strategy in its key markets with the closing of the acquisition of 100% of Central Laundry in the UK.Central Laundry operates one site located in the region of Birmingham. The company’s activity is dedicated to rental-cleaning Flat linen for clients operating in the Healthcare segment and Central Laundry generated revenues of c. £4mn in 2019.This acquisition, which has been in the works for several months, will strengthen Elis’ position as one of the market leaders in the Healthcare sector in the UK.ContactsNicolas Buron Investor Relations Director – Phone: +33 1 75 49 98 30...

Continue reading

Elis finalise l’acquisition de Central Laundry au Royaume-Uni

 Elis finalise l’acquisition de Central Laundryau Royaume-UniSaint Cloud, le 11 mai 2020 – Elis, un prestataire multi-services international, qui fournit des solutions de location-entretien d’articles textiles, d’hygiène et de bien-être, présent en Europe et en Amérique latine, poursuit sa stratégie de consolidation de ses marchés clés avec la finalisation de l’acquisition de 100% de Central Laundry au Royaume-Uni.Central Laundry est une société qui opère une usine dans la région de Birmingham. L’activité est dédiée à la location-entretien de Linge plat pour des clients provenant du secteur de la Santé et Central Laundry a réalisé en 2019 un chiffre d’affaires d’environ 4m£.Cette acquisition, dont le processus était entamé depuis plusieurs mois, permet à Elis de renforcer sa position parmi les acteurs leaders sur le marché...

Continue reading

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2020

Bagsværd, Denmark, 11 May 2020 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.Further informationCompany announcement No 29 / 2020AttachmentCA200511_Insider Trading

Continue reading

Hagar hf. – upplýsingar um birtingu ársuppgjörs 2019/20

Hagar hf. birta ársuppgjör sitt fyrir tímabilið 1. mars 2019 til 29. febrúar 2020, eftir lokun markaða, mánudaginn 18. maí nk.Rafrænn kynningarfundur 19. maí kl. 08:30Kynningarfundur fyrir markaðsaðila og hluthafa verður einungis rafrænn, vegna óvenjulegra aðstæðna og samkomubanns. Kynningunni verður varpað í gegnum netið á slóðinni https://livestream.com/accounts/11153656/events/9126670/player þar sem Finnur Árnason, forstjóri Haga, mun kynna afkomu félagsins fyrir síðasta rekstrarár.Tekið verður við spurningum sem tengjast uppgjörinu á meðan á útsendingu stendur á netfangið fjarfestakynning@hagar.is  og verður þeim svarað eins og kostur er í lok fundar.Kynningargögn verða aðgengileg á heimasíðu Haga, www.hagar.is, við upphaf fundar.

Continue reading

Atlantic American Corporation Reports First Quarter Results for 2020

ATLANTA, May 11, 2020 (GLOBE NEWSWIRE) — Atlantic American Corporation (Nasdaq- AAME) today reported net loss of $8.1 million, or $0.40 per diluted share, in the first quarter of 2020 compared to net income of $4.2 million, or $0.19 per diluted share, in the first quarter of 2019. The increase in net loss is primarily the result of unrealized losses on equity securities of $8.5 million in the current quarter compared to unrealized gains on equity securities of $6.5 million in the prior year quarter. The market value of the Company’s investment portfolio was significantly impacted by the material declines in the capital markets related to the COVID-19 pandemic and related economic developments. Excluding the effects of realized or unrealized gains or losses and taxes, operating loss (as defined below) improved to $2.0 million in...

Continue reading

Monoclonal Antibody Therapy Market to Rise at 14.0% CAGR till 2027; Growing Investment in Product R&D will Create Several Opportunities for Market Growth, says Fortune Business Insights™

Pune, May 11, 2020 (GLOBE NEWSWIRE) — The global monoclonal antibodies therapy market size is projected to reach USD 350.10 billion by the end of 2027. The increasing prevalence of severe diseases such as cancer will create several opportunities for the companies operating in the market. According to a report published by Fortune business Insights, titled “Monoclonal Antibody Therapy Market Size, Share & Industry Analysis, By Type (Human Monoclonal Antibody, Humanized Monoclonal Antibody, Chimeric Monoclonal Antibody, and Murine Monoclonal Antibody), By Application (Cancer, Autoimmune Diseases, and Others), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027,” the market was worth USD 123.03 billion in 2019 and will exhibit a CAGR of 14.0% during the forecast period,...

Continue reading

Ferratum Oyj postpones its Annual General Meeting

Ferratum Oyj postpones its Annual General MeetingHelsinki, 11 May 2020 – The Board of Ferratum Oyj (ISIN: FI4000106299, WKN: A1W9NS) has decided to postpone the date of the Annual General Meeting to 30 June, 2020. All other dates in the Groups financial calendar will remain unchanged:About Ferratum Group:Ferratum Group is an international provider of mobile banking and digital consumer and small business loans, distributed and managed by mobile devices. Founded in 2005 and headquartered in Helsinki, Finland, Ferratum has expanded rapidly to operate in 23 countries across Europe, Africa, South and North America, Australia and Asia.As a pioneer in digital and mobile financial services technology, Ferratum is at the forefront of the digital banking revolution. Ferratum has approximately 740,000 active customers that have an open Mobile Bank...

Continue reading

Verizon and SiriusXM team up to bring SiriusXM with 360L to new Audi vehicles

NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) — Verizon and SiriusXM are teaming up to deliver SiriusXM with 360L – SiriusXM’s newest and most advanced audio entertainment platform – to 11 2021 model year Audi vehicles in the U.S. SiriusXM with 360L combines satellite and streaming content delivery into a single, cohesive in-vehicle entertainment experience. Verizon’s 4G LTE network powers SiriusXM with 360L’s streaming content by delivering fast, reliable in-vehicle access to SiriusXM’s On Demand content in more Audi models than ever before.SiriusXM with 360L upgrades the way subscribers interact with the service by providing more choice in entertainment. Subscribers can tune into their favorite channels live via satellite, while Verizon’s 4G LTE network enables them to access their favorite SiriusXM streaming and On Demand content in...

Continue reading

Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1-March 31, 2020

Message from the CEOIBT is currently developing its lead drug candidate IBP-9414 to prevent necrotizing enterocolitis (NEC), and to improve so called “feeding intolerance” affecting premature infants. Including an additional indication means having multiple independent endpoints for IBP-9414 and may increase the chances of success in the ongoing Phase III study, “The Connection Study” and the product’s future market potential. IBP-9414 contains Lactobacillus reuteri as an active substance, which is a human bacterial strain found naturally in breast milk. This message from the CEO is written in early May 2020 during an ongoing COVID-19 pandemic.It has become more difficult to maintain full activity with our suppliers and a greater number of hospitals are affected to a greater extent as the pandemic continues. Our study is not dependent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.